humira
abbvie deutschland gmbh co. kg - adalimumab - spondylitis, ankylosing; arthritis, juvenile rheumatoid; uveitis; colitis, ulcerative; psoriasis; arthritis, psoriatic; crohn disease; arthritis, rheumatoid - imunosupresíva - pozrite si dokument s informáciami o produkte.
grafalon
neovii biotech gmbh, nemecko - antitymocytový imunoglobulín (králičí) - 59 - immunopraeparata
verorab
sanofi pasteur , francúzsko - očkovacia látka proti besnote, inaktivovaná, neporušený vírus - 59 - immunopraeparata
thymoglobuline 5 mg/ml
sanofi b.v., holandsko - antitymocytový imunoglobulín (králičí) - 59 - immunopraeparata
octagam
octapharma (ip) sprl, belgicko - normálne ľudské imunoglobulíny na intravenózne použitie - 59 - immunopraeparata
varivax
merck sharp & dohme b.v., holandsko - očkovacia látka proti vírusu varicella, živá oslabená - 59 - immunopraeparata
vacteta
biodrug s.r.o., slovensko - tetanový toxoid - 59 - immunopraeparata
idefirix
hansa biopharma ab - imlifidase - desensitization, immunologic; kidney transplantation - imunosupresíva - idefirix is indicated for desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor. the use of idefirix should be reserved for patients unlikely to be transplanted under the available kidney allocation system including prioritisation programmes for highly sensitised patients.
kesimpta
novartis ireland ltd - ofatumumab - roztrúsená skleróza, recidivujúce-odosielajúcej - immunosuppressant - kesimpta is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features (see section 5.
vyvgart
argenx - efgartigimod alfa - myasthenia gravis - imunosupresíva - vyvgart is indicated as an add on to standard therapy for the treatment of adult patients with generalised myasthenia gravis (gmg) who are anti acetylcholine receptor (achr) antibody positive.